304 related articles for article (PubMed ID: 31601031)
1. Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications.
Fernández-Villa D; Aguilar MR; Rojo L
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31601031
[No Abstract] [Full Text] [Related]
2. DNA and RNA synthesis: antifolates.
Kompis IM; Islam K; Then RL
Chem Rev; 2005 Feb; 105(2):593-620. PubMed ID: 15700958
[No Abstract] [Full Text] [Related]
3. Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance.
Gonen N; Assaraf YG
Drug Resist Updat; 2012 Aug; 15(4):183-210. PubMed ID: 22921318
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Folate biosynthesis pathway: mechanisms and insights into drug design for infectious diseases.
Bertacine Dias MV; Santos JC; Libreros-Zúñiga GA; Ribeiro JA; Chavez-Pacheco SM
Future Med Chem; 2018 Apr; 10(8):935-959. PubMed ID: 29629843
[TBL] [Abstract][Full Text] [Related]
6. The discovery of 1, 3-diamino-7H-pyrrol[3, 2-f]quinazoline compounds as potent antimicrobial antifolates.
Li Y; Ouyang Y; Wu H; Wang P; Huang Y; Li X; Chen H; Sun Y; Hu X; Wang X; Li G; Lu Y; Li C; Lu X; Pang J; Nie T; Sang X; Dong L; Dong W; Jiang J; Paterson IC; Yang X; Hong W; Wang H; You X
Eur J Med Chem; 2022 Jan; 228():113979. PubMed ID: 34802838
[TBL] [Abstract][Full Text] [Related]
7. Dihydrofolate reductase inhibitors for use as antimicrobial agents.
He J; Qiao W; An Q; Yang T; Luo Y
Eur J Med Chem; 2020 Jun; 195():112268. PubMed ID: 32298876
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial Antifolates: From Development through Resistance to the Next Generation.
Estrada A; Wright DL; Anderson AC
Cold Spring Harb Perspect Med; 2016 Aug; 6(8):. PubMed ID: 27352799
[TBL] [Abstract][Full Text] [Related]
9. Lipophilic antifolates as candidates against opportunistic infections.
Piper JR; Johnson CA; Hosmer CA; Carter RL; Pfefferkorn ER; Borotz SE; Queener SF
Adv Exp Med Biol; 1993; 338():429-33. PubMed ID: 8304151
[No Abstract] [Full Text] [Related]
10. Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.
Al-Omary FA; Hassan GS; El-Messery SM; Nagi MN; Habib el-SE; El-Subbagh HI
Eur J Med Chem; 2013 May; 63():33-45. PubMed ID: 23454532
[TBL] [Abstract][Full Text] [Related]
11. Repositioning of DHFR Inhibitors.
Lele AC; Mishra DA; Kamil TK; Bhakta S; Degani MS
Curr Top Med Chem; 2016; 16(19):2125-43. PubMed ID: 26881719
[TBL] [Abstract][Full Text] [Related]
12. Non-classical antifolates. Part 2: synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones.
Al-Omary FA; Abou-Zeid LA; Nagi MN; Habib el-SE; Abdel-Aziz AA; El-Azab AS; Abdel-Hamide SG; Al-Omar MA; Al-Obaid AM; El-Subbagh HI
Bioorg Med Chem; 2010 Apr; 18(8):2849-63. PubMed ID: 20350811
[TBL] [Abstract][Full Text] [Related]
13. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
Assaraf YG
Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
[TBL] [Abstract][Full Text] [Related]
14. Folylpoly-γ-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer.
Raz S; Stark M; Assaraf YG
Drug Resist Updat; 2016 Sep; 28():43-64. PubMed ID: 27620954
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial and Immunomodulatory Properties and Applications of Marine-Derived Proteins and Peptides.
Kang HK; Lee HH; Seo CH; Park Y
Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31212723
[TBL] [Abstract][Full Text] [Related]
16. Anticancer antifolates: current status and future directions.
McGuire JJ
Curr Pharm Des; 2003; 9(31):2593-613. PubMed ID: 14529544
[TBL] [Abstract][Full Text] [Related]
17. The antifolates.
Visentin M; Zhao R; Goldman ID
Hematol Oncol Clin North Am; 2012 Jun; 26(3):629-48, ix. PubMed ID: 22520983
[TBL] [Abstract][Full Text] [Related]
18. [Natural peptides with antimicrobial and immunomodulating activity].
Bibikova MV; Egorov AM; Katlinskiĭ AV
Antibiot Khimioter; 2005; 50(8-9):57-66. PubMed ID: 17016913
[No Abstract] [Full Text] [Related]
19. [Pharmacodynamics and bacteriology in sulfamethoxazole-trimetoprim combination therapy].
Bergan T
Tidsskr Nor Laegeforen; 1972 Feb; 92(4):274-7. PubMed ID: 5016492
[No Abstract] [Full Text] [Related]
20. Antifolate agents: a patent review (2006 - 2010).
Wright DL; Anderson AC
Expert Opin Ther Pat; 2011 Sep; 21(9):1293-308. PubMed ID: 21619471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
